NIHR partnership aims to increase research into MND
NIHR is partnering with the MND Association to increase research into MND, starting with career development opportunities for doctoral and postdoc researchers
NIHR is partnering with the MND Association to increase research into MND, starting with career development opportunities for doctoral and postdoc researchers
The NIHR has awarded £97.5m for a Research Support Service, providing support, advice & expertise for all researchers in England across the remit of the NIHR.
New study led by Professor Bart De Strooper discovers Neurons are triggered into programmed cell death following exposure to amyloid plaques and tau tangles.
UK scientists will have access to the world’s largest research collaboration, Horizon Europe, the UK has secured a bespoke deal to allow the participation.
NIHR Evidence has published new work by Dr Piers Daws introducing a new test that could could accurately diagnose dementia in people with hearing problems.
A new NIHR Biomedical Research Centres Study has found that eye scans can identify signs of Parkinson’s disease up to seven years before symptoms may appear
The NIHR has announed an additional £30 million per year to increase research opportunities for healthcare professionals. Supporting new & expanding programmes
A sock which combines sensors with artificial intelligence could help carers and care home staff detect agitation and prevent falls in people with dementia.
Nature Careers – A shift from individual to institutional performance in the next REF exercise is welcome, but ignores realities of academia.
NIHR has awarded over £100m to 20 new Policy Research Units (PRUs) across England. Includes a focus on dementia and neurodegeneration, and end of life care
Funding programme focused on social care research, funding research which generates evidence to improve, expand and strengthen the way social care is delivered
New data reported by Eli Lilly from the TRAILBLAZER-ALZ 2 trial of donanemab at the AAIC, shows that the drug is effective in delaying Alzheimer’s progression.